Financial Statements and Related Announcement::Full Yearly Results
Issuer & Securities
IX BIOPHARMA LTD.
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Financial Statements and Related Announcement
Date &Time of Broadcast
Announcement Sub Title
Full Yearly Results
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please see attached.
For Financial Period Ended
iX Biopharma Ltd 2H22 Final Clean 2022-08-23.pdf
Press Release - iX Biopharma Records Eightfold Rise in FY22 Revenue to S$14.4m - Final.pdf
Total size =735K